Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Global & Regional Health Technology Assessment
|
January 11, 2023
Claudio Jommi, Filippo Cipriani, Francesca Fanelli, et al.
Clinical Therapeutics
|
May 2, 2020
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service
Patrizio Armeni, Ludovica Borsoi, Giulia Fornaro, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 21, 2019
Patient access to oral nutritional supplements: Which policies count?
Marianna Cavazza, Helen Banks, Maurizio Muscaritoli, et al.
Pharmacogenomics
|
June 24, 2014
Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review
Sarah Cargnin, Claudio Jommi, Pier Luigi Canonico, et al.
Clinical Therapeutics
|
June 28, 2020
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service
Patrizio Armeni, Ludovica Borsoi, Giulia Fornaro, et al.
Global & Regional Health Technology Assessment
|
March 20, 2024
Alberto Bortolami, Claudio Jommi, Filippo Bresciani, et al.
International Journal of Technology Assessment in Health Care
|
August 15, 2023
Do France, Germany, and Italy agree on the added therapeutic value of medicines?
Giorgio Casilli, Dario Lidonnici, Claudio Jommi, et al.
Journal of Pharmaceutical Policy and Practice
|
May 17, 2023
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, et al.
Dermatology Practical & Conceptual
|
January 19, 2024
Vitiligo: Unmet Need, Management and Treatment Guidelines
Angelo Valerio Marzano, Silvia Alberti-Violetti, Carlo Alberto Maronese, et al.
Orphanet Journal of Rare Diseases
|
October 20, 2021
Variables affecting pricing of orphan drugs: the Italian case
Claudio Jommi, Elisabetta Listorti, Federico Villa, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Global & Regional Health Technology Assessment
|
January 11, 2023
Claudio Jommi, Filippo Cipriani, Francesca Fanelli, et al.
Clinical Therapeutics
|
May 2, 2020
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service
Patrizio Armeni, Ludovica Borsoi, Giulia Fornaro, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 21, 2019
Patient access to oral nutritional supplements: Which policies count?
Marianna Cavazza, Helen Banks, Maurizio Muscaritoli, et al.
Pharmacogenomics
|
June 24, 2014
Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review
Sarah Cargnin, Claudio Jommi, Pier Luigi Canonico, et al.
Clinical Therapeutics
|
June 28, 2020
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service
Patrizio Armeni, Ludovica Borsoi, Giulia Fornaro, et al.
Global & Regional Health Technology Assessment
|
March 20, 2024
Alberto Bortolami, Claudio Jommi, Filippo Bresciani, et al.
International Journal of Technology Assessment in Health Care
|
August 15, 2023
Do France, Germany, and Italy agree on the added therapeutic value of medicines?
Giorgio Casilli, Dario Lidonnici, Claudio Jommi, et al.
Journal of Pharmaceutical Policy and Practice
|
May 17, 2023
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, et al.
Dermatology Practical & Conceptual
|
January 19, 2024
Vitiligo: Unmet Need, Management and Treatment Guidelines
Angelo Valerio Marzano, Silvia Alberti-Violetti, Carlo Alberto Maronese, et al.
Orphanet Journal of Rare Diseases
|
October 20, 2021
Variables affecting pricing of orphan drugs: the Italian case
Claudio Jommi, Elisabetta Listorti, Federico Villa, et al.
Page
of 9